ow its involvement in the diagnostic products and services markets. Theknown risks uncertainties and other factors affecting these forward-lookingstatements are described from time to time in Transgenomic's reports to theSecurities and Exchange Commission. Any change in such factors risks anduncertainties may cause the actual results events and performance to differmaterially from tho
Date:12/9/2008